Cargando…
Expression of RARRES1 and AGBL2 and progression of conventional renal cell carcinoma
BACKGROUND: Approximately 15% of clinically localised conventional renal cell carcinoma (RCC) will develop metastasis within 5 years of follow-up. The aim of this study was to identify biomarkers predicting the postoperative tumour relapse. METHODS: Tissue microarrays of conventional RCC from a coho...
Autores principales: | Peterfi, Lehel, Banyai, Daniel, Yusenko, Maria V., Bjercke, Thea, Kovacs, Gyula |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283229/ https://www.ncbi.nlm.nih.gov/pubmed/32307444 http://dx.doi.org/10.1038/s41416-020-0798-6 |
Ejemplares similares
-
Expression of TXNIP is associated with angiogenesis and postoperative relapse of conventional renal cell carcinoma
por: Meszaros, Mate, et al.
Publicado: (2021) -
Matrix metalloproteinase 12 is an independent prognostic factor predicting postoperative relapse of conventional renal cell carcinoma - a short report
por: Beres, Bence, et al.
Publicado: (2021) -
Dual role of KRT17: development of papillary renal cell tumor and progression of conventional renal cell carcinoma
por: Sarlos, Donat Peter, et al.
Publicado: (2019) -
FAPα and αSMA mark different subsets of fibroblasts in normal kidney and conventional renal cell carcinoma
por: Peterfi, Lehel, et al.
Publicado: (2022) -
End-stage kidney disease: a never healing wound leading to another never healing wound, renal cancer
por: Docs, Janos, et al.
Publicado: (2023)